A Multi Center Study of Sexual Toxicities After Radiotherapy
The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may improve our underst
| Condition(s) | Malignant Neoplasms |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may improve our understanding of why sexual side effects occur and in turn develop predictive models and biomarkers of sexual side effects and other side effects that may impact sexual function. The results of this study may also lead to improvements in the techniques used to deliver radiotherapy or the development of interventions that will prevent or reduce sexual side effects and improve quality of life for female patients with cancer. |
| Who can participate | Inclusion Criteria: * Patients with female sexual organs ages 18 and older. * Patients must meet at least one of the following two criteria: * have been sexually active in the 36 months prior to initiating cancer treatment. * have the intent to be sexually active in the 24 months following treatment.. * Patients must be able to provide consent and be willing to participate. * Patients must have primary anal, rectal, cervical, uterine, vaginal, or vulvar cancer planned to receive pelvic radiotherapy.\*\* Patients must have an Eastern Cooperative Oncology Group performance status \<=2. Exclusion Criteria: * planned for or undergone extensive pelvic surgery (e.g. pelvic exenteration, non-TME techniques, or surgeries otherwise affecting pudendal neurovasculature); * have clinically or radiolog |
| Ages | 18 Years |
| Sex | Female |
| Lead sponsor | Icahn School of Medicine at Mount Sinai |
| Locations | Atlanta, Georgia, United States; New York, New York, United States; Houston, Texas, United States |
| Start date | 2022-10-04 |
| NCT ID | NCT05394428 |
| Official listing | https://clinicaltrials.gov/study/NCT05394428 |